Authors


MAJDI AL-HASAN, MBBS

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


Nabil Zeineddine, MD

Latest:

A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host

Quick recognition is key to early initiation of treatment and long-term survival.


DAGAN COPPOCK, MD

Latest:

Never Ignore a New Rash in a Patient With AIDS

A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.


Kenny Walter

Latest:

Piperacillin/Tazobactam Reduces Risk of C Difficile, Death

Extended infusion of the antibiotics resulted in fewer patients who died, a shorter length of hospitalization, and lower incidence of C difficile.


LYNN NGUYEN, PHARMD

Latest:

Multidrug-Resistant Pseudomonas aeruginosa Infections: Hard to Treat, But Hope on the Horizon?

Two recently approved agents offer significant activity against these hard-to-treat conditions.


ANN MARIE PORRECA, PHARMD, BCPS

Latest:

Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.


Alexandra Ward, MA

Latest:

ERADICATE: Ceftobiprole Noninferior to Daptomycin for Complicated Staphylococcus aureus Bacteremia

The phase 3 study met its primary and secondary end points of all-cause mortality, microbiological eradication rates, and new Staphylococcus aureus bacteremia complications.


KATHERINE GRUENBERG, PHARMD

Latest:

Multidrug-Resistant Pseudomonas aeruginosa Infections: Hard to Treat, But Hope on the Horizon?

Two recently approved agents offer significant activity against these hard-to-treat conditions.


Paul Sax, MD

Latest:

Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and Advocacy

Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.


Warren Rose, PharmD

Latest:

Synergy Between Antibiotics and The Innate Immune System

Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects


Kristie Zappas, PharmD, BCPS-AQ ID

Latest:

De-Escalation in Under 48 Hours Reduces 90-Day C difficile Infection Incidence 3-Fold

A novel study from Seddon and colleagues adds to the body of evidence that supports what antimicrobial stewardship programs are so often challenged to do, early de-escalation.


Jamie L. Wagner, PharmD

Latest:

Using IL-6 Inhibitors to Treat COVID-19

Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.


Sarah Melvin

Latest:

Inappropriate Antimicrobial Use in the Emergency Department for Skin and Soft Tissue Infections

Studies have shown high rates of inappropriate antibiotic prescribing and opportunity for improvement when it comes to ABSSSIs.


José Mauro Peralta, PhD

Latest:

A True Case Definition of Zika Virus Infection Should Still Be Pursued in Arbovirus Co-Transmission Areas

Differences in the clinical presentations of ZIKV infection which are occurring in different parts of the world might be an obstacle to setting a case definition that is good for use in all areas.


JENNIFER BAILEY, PHARMD

Latest:

New Initiatives for HIV Taking Off This Year

Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.


RAZIEH KEBRIAEI, PHD+

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


MICHAEL J. RYBAK, PHARMD, MPH, PHD+*

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Liza Vaezi, PharmD, MSc, BCPS-AQID

Latest:

Early Adjunctive Corticosteroids Do Not Improve Outcomes in HIV-Negative Adults With PcP

The clinical characteristics and outcomes of Pneumocystis jirovecii pneumonia differ in immunocompromised patients with and without HIV.


Lisa Astor

Latest:

Herpes Zoster Vaccine Subunit Prevents Herpes Zoster Episodes Following HSCT

The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.


Pat Smith

Latest:

Is the Medical Community Behind the Times When It Comes to Treating Lyme?

Lyme Disease Association President, Pat Smith, takes on the major problems surrounding Lyme disease today.




CHRISTOPHER MCCOY, PHARMD, BCPS AQ-ID

Latest:

The Ultimate Infectious Disease Pharmacist Holiday Wish List

In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.


Fatia Kasumu

Latest:

Australian Breakfast Buffet Links Salmonella Outbreak to Eggs

Cross-contamination of eggs is believed to have been the cause of a Salmonella outbreak from an Australian hotel.


Nicola M. Parry, BVSc, MRCVS, MSc, DipACVP ELS

Latest:

Piperacillin-Tazobactam Very Disruptive to Gut Flora

Additionally, its use is associated with colonization of the gastrointestinal tract by lower relative quantities of some potentially protective bacterial organisms.


Jared Kaltwasser

Latest:

CDI Risk Higher for People with COVID-19

The investigators found the risk of hospital-acquired Clostridioides difficile (CDI) infection increased when a hospital switched to serving only coronavirus disease 2019 patients.



John W. Ahern, PharmD*

Latest:

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.


Rachel V. Marini, PharmD*

Latest:

The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections

Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.


John Parkinson

Latest:

Maximum Dose of Ivermectin Does Not Improve COVID-19 Recovery Time

A midsized study demonstrated no therapeutic benefit to patients with mild-to-moderate COVID-19 taking this class of anthelmintics.

© 2023 MJH Life Sciences

All rights reserved.